Oral e-Poster Presentations - Booth 2: Neuro-Oncology 1 (GBM & malignant gliomas), Neuro-Oncology 2 (GBM & malignant gliomas)
Tracks
Mezzanine Floor
| Tuesday, October 15, 2024 |
| 12:40 PM - 2:10 PM |
| Mezzanine Floor |
Details
Oral e-Posters: 3 minutes presentation duration each
Speakers & Chairs
Dr Eric Suero Molina
Consultant
University Hospital Münster
Chair
Dr Anastasia Tasiou
Dr.
University Hospital of Larissa
Chair
Mr Diyan Dimov
Resident
University Hospital Owl, Campus Bielefeld-bethel
Preoperative epilepsy is an independent predictive factor for overall survival in Glioblastoma patients - a Bi-Center Analysis of 597 patients
Dr Gilbert Hangel
Principal Investigator
Medical University of Vienna
7T MRSI-based k-means clustering of glioma
Dr Vera Nickl
Resident
Section Experimental Neurosurgery
Enhancing Glioblastoma Immunotherapy: Synergistic Effects of CAR T-Cells and Checkpoint Inhibitors in a patient-derived ex vivo Glioblastoma Organoid Model
Dr Vera Nickl
Resident
Section Experimental Neurosurgery
Overcoming Antigen Escape Mechanisms in Glioblastoma: A Combined CAR T-Cell Approach for Ex Vivo and In Vivo Models
Dr Vera Nickl
Resident
Section Experimental Neurosurgery
Exploring the Gut Microbiome and Mycobiome in Glioblastoma Patients
Dr Alice Dauth
Resident
University Medical Center of Johannes Gutenberg-University Mainz
The value of salvage therapy in recurrent glioblastoma
Dr Johannes Wach
Attending
University Hospital Leipzig
Impact of continuous levetiracetam use in glioblastoma: An Individual Patient-Level Meta-Analysis Assessing Overall Survival
Dr João Gonçalves
Doctor
Centro Hospitalar Universitario do São João
Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients
Dr Carlo Gambacciani
Md
Ospedali Riuniti Livorno
Implementation of ReSECT categories for EOR stress the long-term clinical benefit of supramaximal CE resection in a retrospective cohort of newly diagnosed IDHwt GBM patients
Dr Severina Leu
Attending
University Hospital Of Basel
Proteomic analysis of glioma reveals distinct signatures of proteins and pathways among glioma subgroups
Dr Sara Huskić
PhD Student
Medical University of Vienna
Preliminary insights into the correlations between 5-ALA fluorescence and 7T MRSI in gliomas
Mr Sagar Acharya
Phd Student
Department of Neurosurgery, Medical University Of Vienna
Intraoperative Precision Sampling of Tumor Microenvironments based on 7T MRSI: A pipeline development
Dr Alice Ryba
Resident
University Medical Center Hamburg-Eppendorf
Elevated BDNF Levels in Glioblastoma Patients: Exploring the Impact on T Cell Function
Dr Alice Ryba
Resident
University Medical Center Hamburg-Eppendorf
Sex-biased immune response in glioblastoma patients
Dr Lisa Hoenikl
Resident
Klinikum Rechts der Isar
Molecular differences in long- and short-time survivors of GBM patients
Dr Julien Haemmerli
Attending
Geneva University Hospitals
Mixed reality-guided glioblastoma resection compared to standard procedures: assessing the surgical and clinical benefits of the virtual world in tumor surgery
Dr Giovanni Raffa
Assistant Professor
University Of Messina, Italy
The Influence of Frailty score on the treatment of Glioblastoma patients: Insights from a Retrospective Multicenter Analysis
Dr Obada Alhalabi
Resident
Heidelberg University Hospital
Re-Resection For Recurrent Glioblastoma – Does Timing Matter?
